A comparative study of medication use after stroke in four countries

Area of Science:

• Neurology
• Pharmacology
• Public Health

Background:

• Medication is crucial for secondary stroke prevention and managing post-stroke conditions.
• The Collaborative Evaluation of Rehabilitation in Stroke across Europe (CERISE) study examined stroke rehabilitation across four European countries.

Purpose of the Study:

• To compare medication use five years post-stroke among patients in Belgium, Germany, the UK, and Switzerland.
• To assess secondary stroke prevention strategies, including antithrombotic therapy, comorbidity management, and lipid-lowering drug use.
• To evaluate the treatment of stroke-related disorders like depression, anxiety, and pain.

Main Methods:

• A comparative analysis of patient medication data from four European centers (Belgium, Germany, UK, Switzerland).
• Focus on cerebrovascular secondary prevention and treatment of associated comorbidities and psychological disorders.
• Data collected from 247 patients for medication use and 233 for depression and anxiety.

Main Results:

• No significant differences were found in antithrombotic, cardiovascular comorbidity, or diabetes treatment across the four countries.
• UK patients showed higher utilization of lipid-lowering drugs compared to Belgian patients.
• Significant variations in depression prevalence and treatment were observed, with Belgian patients experiencing higher rates and antidepressant use compared to German patients.

Conclusions:

• While core secondary stroke prevention treatments were consistent across centers, variations exist in managing specific conditions like depression.
• Lipid-lowering drug prescription and depression management highlight country-specific differences in post-stroke care.
• A notable percentage of patients with pain did not receive specific medication, indicating a potential gap in pain management.